Target intelligence / Profile preview

D-Xylose (Xyl)

Target
Xyl
Molecular classification
Carbohydrate, Monosaccharide, Pentose, Other
01

Overview

D-Xylose is a five-carbon monosaccharide, commonly known as wood sugar, that is primarily utilized in clinical medicine as a diagnostic tool rather than a therapeutic target [1]. It is the central component of the D-xylose absorption test, which assesses the functional integrity of the small intestinal mucosa to distinguish between malabsorption syndromes and pancreatic insufficiency [2][3]. Upon oral administration, D-xylose is absorbed by the duodenum and jejunum and excreted primarily by the kidneys, providing a measurable index of intestinal surface area and transport efficiency [4]. While it serves as a natural substrate for the initiation of glycosaminoglycan chain synthesis in human proteoglycans, there are no established pharmaceutical drugs that target the xylose molecule for therapeutic modulation [1][4]. Consequently, its significance in biotechnology and medicine is confined to its role as a diagnostic agent and a structural component in carbohydrate chemistry [2].

Other names
Wood sugar(+)-XyloseD-xylopyranoseXylopyranose
02

Mechanism of action

Used as a diagnostic substrate administered orally; it is absorbed in the proximal small intestine via passive diffusion and facilitated transport, and then excreted unchanged in the urine to measure mucosal absorptive capacity [2][4].

03

Biological functions

Diagnostic marker for intestinal absorption [2]Structural component of plant hemicellulose [1]Substrate for xylosyltransferases in proteoglycan synthesis [4]Metabolic intermediate in the pentose phosphate pathway (in some organisms) [1]
04

Disease associations

Celiac disease [2]Crohn's disease [2]Small intestinal bacterial overgrowth (SIBO) [3]Whipple's disease [3]Tropical sprue [2]
05

Safety considerations

Osmotic diarrhea at high diagnostic doses [2]Abdominal cramping and bloating [2]Diagnostic inaccuracy in patients with renal impairment [3]Dehydration [2]
06

Biomarkers

Serum D-xylose concentration [2]5-hour urinary xylose excretion [3]

Beyond the preview

Go deeper on D-Xylose (Xyl).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on D-Xylose (Xyl).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call